While taking Mounjaro, a prescription medicine that helps to manage type 2 diabetes and weight, people may experience a few ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss ...

Mounjaro (tirzepatide) is a newly approved medication for type 2 diabetes by the FDA. It belongs to a novel class of drugs ...

About four months into taking Mounjaro —a GLP-1 drug traditionally used to help patients with type 2 diabetes manage their weight — Kyle Richards and Mauricio Umansky’s daughter opened up ...

Hansal Mehta revealed on X that Mounjaro is the type 2 diabetes medication that has worked to jumpstart his weight loss. He also shared new photos of himself. Hansal Mehta said he 'began Mounjaro ...

Prior to Friday’s game Boston placed right-hander Walker Buehler on the 15-day injured list with right shoulder bursitis and called up rookie Hunter Dobbins to fill his spot in the rotation.

Eli Lilly's blockbuster diabetes treatment Mounjaro topped expectations for the first quarter, raking in $3.84 billion in revenue. That's up a whopping 113% from the same period a year ago.

Eli Lilly and Company LLY reported first-quarter 2025 adjusted earnings per share (“EPS”) of $3.34, which missed the Zacks Consensus Estimate of $3.52 per share. Earnings rose 29% year over year.